Blog

Douglas Flora: Donating $1,000 to Cancer Family Care, Inc. to help feed cancer patients in need

medium.com

Jan 14, 2025, 03:39

Douglas Flora: Donating $1,000 to Cancer Family Care, Inc. to help feed cancer patients in need

Douglas Flora shared on LinkedIn:

“Wow! Our Substack community has absolutely exploded in just a few days! I’m genuinely touched by your incredible support.

For those who haven’t joined yet – we’re building something special here. Each post brings you curated insights on AI developments, book recommendations, music discoveries, and some hoped inspiration to help you become your best self.

But here’s what makes this community truly meaningful: Your subscriptions are powering real change. I’m thrilled to announce our first milestone – we’re donating $1,000 to Cancer Family Care, Inc. to help feed cancer patients in need.

The need is especially urgent right now. Our local Freestore Foodbank recently lost a crucial grant, leaving food pantry shelves empty. Cancer patients and their families need our support more than ever. 100 percent of any donations will be spent on the patients we care about—no donation is too small.

Thank you Jill Settlemyre and your Cancer Family Care team for your help addressing this critical need.

Want to be part of this journey? You can:

1. Subscribe to our Substack (check my recent posts for the link)
2. Donate directly to Cancer Family Care, Inc:
3. Share this post to spread the word

Together, we can make a real difference while building an engaged community focused on growth, learning, and giving back. Thank you all! ”

Additional information.

Douglas Flora is the Executive Medical Director of Oncology Services at St. Elizabeth Healthcare, overseeing clinical operations, strategic planning, and the expansion of cancer programs. He is also the co-founder of the Center for Precision Medicine; Genomic Health and the Leader of the AI and HealthCare Team for the Cincinnati AI Catalyst (CaiC).

As the Editor-in-Chief of ‘AI in Precision Oncology,’ the first peer-reviewed academic journal dedicated to this field, he plays a pivotal role in advancing research. He is also an active board member of the American Cancer Society and ACCC, where he contributes to advocacy, education, and innovation within the cancer community.